India's Gland Pharma to produce, supply up to 252 mln Sputnik V vaccine doses

Reuters · 03/16/2021 09:07
India's Gland Pharma to produce, supply up to 252 mln Sputnik V vaccine doses

- India's Gland Pharma Ltd GLAD.NS said on Tuesday it has entered into an agreement with the Russian Direct Investment Fund to produce and supply up to 252 million doses of the Sputnik V COVID-19 vaccine.


(Reporting by Anuron Kumar Mitra in Bengaluru; Editing by Arun Koyyur)

((AnuronKumar.Mitra@thomsonreuters.com; +91 99863 58469;))